125 related articles for article (PubMed ID: 8761594)
1. [Specificities of antibacterial activity of zwitterionic 7-methoxyimino cephems (cephalosporins of fourth generation].
Pechère JC
Pathol Biol (Paris); 1996 Feb; 44(2):99-105. PubMed ID: 8761594
[TBL] [Abstract][Full Text] [Related]
2. Laboratory assessment of antibacterial activity of zwitterionic 7-methoxyimino cephalosporins.
Pechère JC; Wilson W; Neu H
J Antimicrob Chemother; 1995 Nov; 36(5):757-71. PubMed ID: 8626256
[TBL] [Abstract][Full Text] [Related]
3. CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships.
Masakitsushima ; Iwamatsu K; Umemura E; Kudo T; Sato Y; Shiokawa S; Takizawa H; Kano Y; Kobayashi K; Ida T; Tamura A; Atsumi K
Bioorg Med Chem; 2000 Dec; 8(12):2781-9. PubMed ID: 11131169
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
Nishino T; Otsuki M; Hatano K; Nishihara Y
Chemotherapy; 1994; 40(3):167-82. PubMed ID: 8205935
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antibacterial activities of 3-thiazol-4-yl-1-carba-1-dethiacephalosporins.
Hornback WJ; Munroe JE; Counter FT
J Antibiot (Tokyo); 1994 Sep; 47(9):1052-64. PubMed ID: 7928693
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.
Frei R; Jones RN; Pignatari AC; Yamane N; Marco F; Hoban DJ
Diagn Microbiol Infect Dis; 1994 Mar; 18(3):167-73. PubMed ID: 7924209
[TBL] [Abstract][Full Text] [Related]
7. The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria.
Zhang YL; Li JT
Int J Antimicrob Agents; 2001 Feb; 17(2):143-6. PubMed ID: 11165119
[TBL] [Abstract][Full Text] [Related]
8. In-vitro antibacterial activity of DQ-2556 and its stability to various beta-lactamases.
Fujimoto T; Watanabe M; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1990 Sep; 26(3):329-41. PubMed ID: 2228824
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactamase stability and antibacterial activity of cefpirome alone and in combination with other antibiotics.
Bakhtiar M; Selwyn S
Drugs Exp Clin Res; 1989; 15(10):477-82. PubMed ID: 2698794
[TBL] [Abstract][Full Text] [Related]
10. In vitro activities of novel oxapenems, alone and in combination with ceftazidime, against gram-positive and gram-negative organisms.
Jamieson CE; Lambert PA; Simpson IN
Antimicrob Agents Chemother; 2003 Aug; 47(8):2615-8. PubMed ID: 12878527
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguti O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
Jpn J Antibiot; 2006 Jun; 59(3):177-200. PubMed ID: 16913404
[TBL] [Abstract][Full Text] [Related]
13. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent gram-positive and gram-negative isolates of European origin.
Pillar CM; Aranza MK; Shah D; Sahm DF
J Antimicrob Chemother; 2008 Mar; 61(3):595-602. PubMed ID: 18218646
[TBL] [Abstract][Full Text] [Related]
15. In-vitro and in-vivo antimicrobial activities of a novel cephalosporin derivative, CP6162, possessing a dihydroxypyridone moiety at the C-3 side chain.
Orikasa Y; Hara T; Miyata A; Tamura A; Kawaharajo K; Matsumoto T; Komiya I; Iwamatsu K; Shibahara S; Inouye S
J Antimicrob Chemother; 1991 Jan; 27(1):41-53. PubMed ID: 2050596
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological properties of a series of optically active 2-oxaisocephems.
Tsubouchi H; Ishikawa H
Bioorg Med Chem; 1995 Feb; 3(2):143-50. PubMed ID: 7796047
[TBL] [Abstract][Full Text] [Related]
17. [Antibiotic activities of cefpirome against fresh clinical isolates resistant to multiple drugs].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1994 Feb; 47(2):143-60. PubMed ID: 8151908
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Fritsche TR; Sader HS; Jones RN
Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
[TBL] [Abstract][Full Text] [Related]
19. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
Jones ME
Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activities of ME1220 and ME1221, novel cephalosporins.
Okamoto R; Tamura A; Yoshida T; Komiya I; Ogino H; Inouye S; Kondo S; Inoue M; Mitsuhashi S
Drugs Exp Clin Res; 1991; 17(4):205-12. PubMed ID: 1794294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
